Fertility I Menopause I Sexual Wellness
11:00 CET 10:00 BST 05:00 ET
Hear from six of the most exciting growth companies in women’s health about who they are, why their customers love them and how they are tackling consumer health and wellness for a post-pandemic era.
Callaly is a new British femcare company based in London named one of the “period-positive startups revolutionising the multi-billion pound feminine care industry by the Independent and one of the UK's 50 leading D2C companies by the IAB.
Thang Vo-Ta, CEO & Co-Founder, Callaly
13:00 CET 12:00 BST 07:00 EDT
Women’s health is gaining ground as an important market segment. But it still desperately needs more investment. This session looks at why women’s health is so lucrative and how it extends beyond Femtech to complex medical solutions. It also looks at how to stimulate investment in female founders and putting women’s health at the top of more VC agendas.
Marie Laure Mahe, Vice President Business Development, Europe, Essity Ventures
Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures
Deepali Nangia, Co-Founder, Alma Angels
Maria Velissaris, Managing Partner, SteelSky Ventures
14:00 CET 13:00 BST 08:00 EDT
The sexual wellbeing market is growing quickly, but few innovators recognise the opportunity of marketing to adults in later life. Instead, the myth prevails that sex stops at fifty. Find out why that is a load of nonsense, what the real market opportunity is from older adults and how to access it.
Samantha Evans, Director, Jo Divine
Adam Lewis, Chief Executive Officer, Hot Octopuss
Jackie Marshall-Cyrus, Ageing Innovation Strategist
Eva Goicochea, Founder and CEO, Maude
Moderator: Rachel Scherl, Founder and CEO, SPARK Solutions for Growth
15:00 CET 14:00 BST 09:00 EDT
Ask the investors (EU)
Get in front of European investors in women’s health and female founders. This interactive roundtable-style session is designed for emerging brands to put their questions to and build relationships with investors in their space.
Investors include:
Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures
Deepali Nangia, Co-Founder, Alma Angels
16:00 CET 15:00 BST 10:00 EDT
Panel: “Women’s health is global health” – seizing market opportunities in period care, incontinence and sexual wellbeing
Some of the world’s most interesting SMEs tackling an array of women’s health concerns including period care, incontinence and sexual wellbeing look at how to launch a successful women’s health brand including busting taboos, fund raising, product manufacturing, distribution and marketing.
Gloria Kolb, Co-Founder and CEO, Elidah
Frances Tang, Founder, Awkward Essentials
Daniella Peri, CEO, Yoppie
Arion Long, Founder and CEO, Femly
18:00 CET 17:00 BST 12:00 EDT 9:00 PST
Ask the investors (US)
Get in front of US investors in women’s health and female founders. This interactive roundtable-style session is designed for emerging brands to put their questions to and build relationships with investors in their space.
Investors include:
Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital
Elizabeth Bailey, Managing Director, Rhia Ventures
Maria Velissaris, Managing Partner, SteelSky Ventures
Moderator: Alice Zheng, Engagement Manager, McKinsey & Co
19:00 CET 18:00 BST 13:00 EDT 10:00 PST
Menopause as a movement
Menopause is one of the most attractive and investible segments of the women’s health market. It’s a huge market offering limited solutions and is finally starting to cut through the taboo of old. Welcome to menopause as a movement! This session explores how emerging businesses are accessing the menopause market opportunity and creating the next big consumer trend in the meantime.
Kate Bache, Co-Founder and CEO, Health & Her
Rochelle Weitzner, Founder and CEO, The Pause Group
Peter Astbury, Founder, Grace
Jill Angelo, Founder and CEO, Gennev
20:00 CET 19:00 BST 14:00 EDT 11:00 PST
Panel: Commercialisation of pre- and post-natal health platforms
Conception, pregnancy, birth and post-natal recovery is all pretty run-of-the mill stuff, right? Said no woman ever! The number of reported pregnancy-related death in the US has increased from 7.2 per 100,000 births in 1987 to 17.3 per 100,000 births in 2017. We need to take pregnancy – including pre- and post-natal health – more seriously. This session looks at how assorted stakeholders are rising to the challenge, and how to do so commercially.
Melinda Nicci, Founder and CEO, Baby 2 Body
Carrie Yang, Founder, Gynii Me
Susan Nicholson, Vice President, Women’s Health, Johnson & Johnson
Elizabeth Bailey, Managing Director, Rhia Ventures
Moderator: Anula Jayasuriya, Founder and Managing Director, EXXclaim Capital
